This is a heavily interactive web application, and JavaScript is required. Simple HTML interfaces are possible, but that is not what this is.
Post
Newsramp
newsramp.com
did:plc:xlsujlrwr5xpfxgaf4pixhri
NanoViricides advances broad-spectrum antiviral NV-387 following Andes hantavirus incident. Phase I trial completed successfully; animal models show efficacy against COVID, RSV, influenza, and monkeypox. #Biotech #Antivirals
2026-05-15T02:59:51.972Z